SOLY

Soliton, Inc. [SOLY] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

SOLY Stock Summary

In the News

SOLY Financial details

Company Rating
-
Market Cap
0
Income
-17.88M
Revenue
370K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
13
Optionable
No
Shortable
Yes
Earnings
16 Dec 2021
P/E
-21.49
Forward P/E
-
PEG
15.48
P/S
-
P/B
10.09
P/C
-
P/FCF
-
Quick Ratio
11.19
Current Ratio
11.44
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.85
EPS next Y
-
EPS next Q
-
EPS this Y
6.06%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-96.59%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-43%
ROE
-70%
ROC
-0.46%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
22.56-22.59
52W High
+2.64%
52W Low
+2.64%
RSI
-
Rel Volume
7.37
Avg Volume
182.84K
Volume
1.35M
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.183889
-
-
Volatility
0%, 0%
Prev Close
0%
Price
22.58
Change
0.09%

Something similar

Top by Market Cap
MSF.DE
1YD.DE
AMZN
META
ABEA.DE
Same Sector
1875.HK
300253.SZ
PULM
TCRT
600513.SS
Check Those
BHK
IDLB
ALTR.LS
FMIYX
RCAR
Similar Market Cap
ONTEX.BR
CMG.TO
NOL.OL
9749.T
LITI.ST

Company Profile

Healthcare Medical - Devices
  • Volume Average 182.84K
  • Employee 13
  • CEO Dr. Christopher C. Capelli
  • Headquarters Houston,TEXAS,US
  • IPO Date 2019-02-19
  • Website https://www.soliton.com

Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.